Delhivery Limited — Updates, 07-02-2025: Press Release

Delhivery has appointed Ms. Namita Thapar, currently an Executive Director at Emcure Pharmaceuticals, as a Non-Executive Independent Director on its Board, effective February 17, 2025. Namita brings a wealth of experience, having led Emcure's India business, which generates approximately 8000 Cr in annual revenue. Her prior experience includes six years at Guidant Corporation in the USA. Ms. Thapar, an MBA from Duke University and a Chartered Accountant, is also a prominent figure on "Shark Tank India." Managing Director and CEO Sahil Barua expressed excitement about Namita's appointment, highlighting her expertise in high-growth business leadership and healthcare innovation as valuable to Delhivery's strategic direction. This addition strengthens the leadership team, which could positively influence the company's growth trajectory.